Not applicableStudy completedNCT01411423What this trial is testingNexavar Post-marketing Surveillance for Renal Cell Carcinoma in JapanWho this might be right forCarcinoma, Renal Cell Bayer 3,305
Not applicableEnded earlyNCT01117779What this trial is testingTracking Renal Tumors After Cryoablation EvaluationWho this might be right forKidney Neoplasms Boston Scientific Corporation 246
Testing effectiveness (Phase 2)Study completedNCT02862288What this trial is testingPreliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.Who this might be right forLung TumorBone TumorRenal Tumor Centre Hospitalier Universitaire de Besancon 30
Testing effectiveness (Phase 2)Study completedNCT02082210What this trial is testingEmibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced CancerWho this might be right forAdvanced CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+3 more Eli Lilly and Company 97
Testing effectiveness (Phase 2)Ended earlyNCT02446860What this trial is testingAnti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)Who this might be right forRenal Cell Carcinoma Royal Marsden NHS Foundation Trust 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more National Cancer Institute (NCI) 6,452
Testing effectiveness (Phase 2)Study completedNCT03207347What this trial is testingA Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)Who this might be right forMesotheliomaUveal MelanomaRenal Cell Carcinoma+1 more University of Florida 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03355976What this trial is testingBrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell CarcinomasWho this might be right forOvarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+2 more Brown University 46
Testing effectiveness (Phase 2)Study completedNCT00276614What this trial is testingBortezomib in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Jonsson Comprehensive Cancer Center 4
Not applicableLooking for participantsNCT07743749What this trial is testingAn MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal TumorsWho this might be right forRenal TumorKidney Neoplasm Cancer Institute and Hospital, Chinese Academy of Medical Sciences 900
Early research (Phase 1)Ended earlyNCT06336148What this trial is testingA Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Actym Therapeutics, Inc. 10
Not applicableEnded earlyNCT01466504What this trial is testingEffect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human SkinWho this might be right forRenal Cell CarcinomaHepatocellular CarcinomaColorectal Carcinoma Dartmouth-Hitchcock Medical Center 4
Testing effectiveness (Phase 2)WithdrawnNCT03540199What this trial is testingStudy of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney CancerWho this might be right forAdvanced Kidney Cancer Fuda Cancer Hospital, Guangzhou
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07346404What this trial is testingDynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney CarcinomaWho this might be right forRenal Cell Carcinoma Assistance Publique - Hôpitaux de Paris 50
Early research (Phase 1)Looking for participantsNCT06819293What this trial is testingIB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced Clear Renal Cell CarcinomaAdult Grit Biotechnology 12
Not applicableLooking for participantsNCT04892849What this trial is testingClinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and RadiotherapyWho this might be right forHNSCCNSCLCEsophageal Cancer+4 more University of Erlangen-Nürnberg Medical School 200
Not applicableUnknownNCT01529658What this trial is testingRenal Hypothermia During Partial NephrectomyWho this might be right forRenal ImpairmentKidney DiseasesUrologic Diseases+3 more Ottawa Hospital Research Institute 184
Testing effectiveness (Phase 2)Study completedNCT00003408What this trial is testingBiological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Cancer Treatment Centers of America 40
Testing effectiveness (Phase 2)Study completedNCT00024258What this trial is testingArsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more Memorial Sloan Kettering Cancer Center 22
Not applicableActive Not RecruitingNCT05871008What this trial is testingIntegrated Actionable Aging Assessment for Cancer Patients PilotWho this might be right forBreast CancerHodgkin LymphomaKidney Cancer+7 more University of Colorado, Denver 35